Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mandy Hubatsch"'
Autor:
Henning Plage, Kira Furlano, Jörg Neymeyer, Sarah Weinberger, Benedikt Gerdes, Mandy Hubatsch, Bernhard Ralla, Antonia Franz, Annika Fendler, Michela deMartino, Florian Roßner, Simon Schallenberg, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Henrik Zecha, Marcin Slojewski
Publikováno v:
BJUI Compass, Vol 5, Iss 6, Pp 585-592 (2024)
Abstract Objectives Carcinoembryonic antigen (CEA) is a cell surface glycoprotein that represents a promising therapeutic target. Serum measurement of shedded CEA can be utilized for monitoring of cancer patients. Material and Methods To evaluate the
Externí odkaz:
https://doaj.org/article/81a61db9b6264355b1ed85e97fb6d1fe
Autor:
Heinrich Schulte-Baukloh, Catarina Weiß, Sarah Weinberger, Mandy Hubatsch, Thorsten Schlomm, Bernhard Ralla
Publikováno v:
Toxins, Vol 15, Iss 1, p 30 (2022)
Introduction: Detrusor injection with onabotulinumtoxin A (OnabotA-DI) is an established therapy for overactive bladder (OAB). Little is known about the exact onset and course of the effect in the days after the injection therapy. By using a new type
Externí odkaz:
https://doaj.org/article/9a64158b0206417d9c80605b1df3080d
Autor:
Heinrich Schulte-Baukloh, Dirk Höppner, Mandy Hubatsch, Katharina Mala, Thorsten Schlomm, Sarah Weinberger
Publikováno v:
Aktuelle Urologie. 54:55-60
Zusammenfassung Hintergrund OnabotulinumtoxinA (Botox) ist in Deutschland seit 2013 nach Versagen einer anticholinergen Therapie für die Second-line Behandlung der idiopathischen überaktiven Harnblase als Detrusorinjektion (OnabotA-DI) zugelassen.
Publikováno v:
Journal of Clinical Medicine. 12:3317
Ureteral complications such as urinary leak, ureteral necrosis or ureteral stenosis are common complications after renal transplantation with major short- and long-term issues, including graft impairment and graft loss. At present, there is no agreem
Autor:
Sarah Weinberger, Mandy Hubatsch, Nasrin El-Bandar, Andreas Maxeiner, Frank Friedersdorff, Robert Peters
Publikováno v:
Urologia internationalis. 104(11-12)
We report 2 cases of de novo renal cell carcinoma (RCC) in renal grafts after transplantation. Both patients underwent nephron sparing surgery (NSS) 211 and 167 months after transplantation, revealing papillary RCC with a tumour size >4 cm (pT1a). Wi
Autor:
Frank Friedersdorff, Markus Herbert Lerchbaumer, Isabel Michaela Lichy, Mandy Hubatsch, Matthias Schulz, Nasrin El-Bandar
Kidney transplantation is the treatment of choice for patients with ESRD. One rare complication after transplantation is the development of renal allograft compartment syndrome (RACS). We present a case of 1 patient who developed RACS due to compress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309434b90e234f55c4586b6d458ca42b
https://refubium.fu-berlin.de/handle/fub188/32318
https://refubium.fu-berlin.de/handle/fub188/32318